BMY vs DARE · P/E 17, rev $24.46B vs rev $187.5K
Bristol-Myers Squibb Company (BMY) versus Dare Bioscience Inc (DARE) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DARE currently screens at market cap $21.2M.
Not investment advice. Open the BMY and DARE stock pages for the full models.
Not investment advice.